1st Quarter - Amendment

ASSOCIATION FOR COMMUNITY AFFILIATED PLANS for ASSOCIATION FOR COMMUNITY AFFILIATED PLANS

Firm
Client
Income
—
Expenses
$80,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report Apr 19, 2017 $80,000 Replaced
1st Quarter - Amendment (this page) Jun 7, 2017 $80,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Affordable Care Act implementation with respect to safety net health plans; Continuous eligibility and coordination between Medicaid and Marketplace to support continuous care; Federally Facilitated Marketplace implementation; Network adequacy; Risk adjustment; Strategies to address substance use disorders; Availability of premium tax credits for enrollees in the Federally Facilitated Marketplace; Basic Health Program; Health insurance providers fee; S.Con.Res.3, related to Health Insurance Exchanges; H.R.1628, American Health Care Act; Cost sharing reductions (CSR); Marketing rule consistency across Medicaid and the Exchange

LobbyistCovered position, as disclosed
JENNIFER ANN BABCOCK —
HEATHER J FOSTER Senior Policy Advisor; Congresswoman Diana DeGette
CHRISTINE LYNCH —
MARGARET MURRAY —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); White House Office; Office of Management & Budget (OMB); Medicare Payment Advisory Commission (MedPAC); Congressional Budget Office (CBO); SENATE; Centers For Disease Control & Prevention (CDC)

Bills named: S.Con.Res. 3 (115th), H.R. 1628 (115th)

Medicare/Medicaid MMM

340B drug discount program Actuarial soundness Appropriate payment, including risk adjustment, for D-SNPs and MMPs Appropriate quality measurement for D-SNPs and MMPs Changes to Medicare/Medicaid programs as part of entitlement reform and deficit reduction efforts Education, implementation, evaluation, and improvement of coordinated care programs for dual eligibles Fraud, waste, and abuse issues for Medicare and Medicaid High cost specialty medications Impact of significant budget cuts in Medicaid Legislative solution to address churning in Medicaid/CHIP eligibility and improve quality measurement in both programs Medicaid and Medicare reform discussions with MACPAC and MedPAC Medicaid eligibility and enrollment issues Medicaid health plans serving as qualified health plans in the Exchange Medicaid managed care best practices Medicaid managed care regulations Medicaid Provider Payments Medicaid quality measurement and improvement Mental Health Parity Network adequacy Protecting Medicaid from reductions made during budget reconciliation Provider Directories Regulatory and systematic impact of Medicaid continuous coverage Risk adjustment SNP reauthorization SNP sustainability and improvements to MMPs Medicaid expansion activities Medicaid state financing mechanisms Capped Medicaid Funding Proposals CHIP funding extension Generic medications Home and community based services Impact of enhanced state flexibility in managing Medicaid programs Marketing rule consistency across Medicaid and the Exchange Medicaid eligibility programs including TMA and QI Medicaid managed care external quality review standards Medicaid PCP rate increase Medical loss ratio for Medicaid managed care plans Psychotropic medication use among foster care children S.Con.Res.3, related to Medicaid H.R.1628, American Health Care Act Substance Use Disorder Treatment Privacy Protections (42 CFR Part 2)

LobbyistCovered position, as disclosed
JENNIFER ANN BABCOCK —
HEATHER J FOSTER Senior Policy Advisor; Congresswoman Diana DeGette
CHRISTINE LYNCH —
MARGARET MURRAY —

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); SENATE; White House Office; Office of Management & Budget (OMB); Congressional Budget Office (CBO); Medicare Payment Advisory Commission (MedPAC)

Bills named: S.Con.Res. 3 (115th), H.R. 1628 (115th)

Budget/Appropriations BUD

Health provisions of budget proposals; Protecting Medicaid from reductions made during budget reconciliation; H.R.1628, American Health Care Act

LobbyistCovered position, as disclosed
JENNIFER ANN BABCOCK —
HEATHER J FOSTER —
CHRISTINE LYNCH —
MARGARET MURRAY —

Contacted: Medicare Payment Advisory Commission (MedPAC); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; White House Office; Health & Human Services, Dept of (HHS); SENATE; Congressional Budget Office (CBO); Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC)

Bills named: H.R. 1628 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.